<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ChemRoutes</title>
	<atom:link href="http://www.chemroutes.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.chemroutes.com</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Fri, 05 Mar 2010 21:35:40 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>ChemDiscovery Platform™</title>
		<link>http://www.chemroutes.com/2010/03/new-post/</link>
		<comments>http://www.chemroutes.com/2010/03/new-post/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 12:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ChemDiscovery Platform™]]></category>

		<guid isPermaLink="false">http://www.chemroutes.com/?p=59</guid>
		<description><![CDATA[ChemRoutes Corporation is pleased to announce its first series of ChemArrays™ libraries targeting novel oncology based targets. For more information contact us at info@chemroutes.com
In its natural product collection of chemical compounds, ChemRoutes Corporation is pleased to announce its second series of compound collections. This series is based on novel quinine derivatives aimed at infectious disease research [...]]]></description>
			<content:encoded><![CDATA[<p>ChemRoutes Corporation is pleased to announce its first series of ChemArrays™ libraries targeting novel oncology based targets. For more information contact us at <a href="mailto:info@chemroutes.com">info@chemroutes.com</a></p>
<p>In its natural product collection of chemical compounds, ChemRoutes Corporation is pleased to announce its second series of compound collections. This series is based on novel quinine derivatives aimed at infectious disease research targets and is also useful for pain and inflammation research programs. For additional information contact us at <a href="mailto:info@chemroutes.com">info@chemroutes.com</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chemroutes.com/2010/03/new-post/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Corporate News</title>
		<link>http://www.chemroutes.com/2010/03/hello-world/</link>
		<comments>http://www.chemroutes.com/2010/03/hello-world/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 12:00:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Corporate News]]></category>

		<guid isPermaLink="false">http://www.chemroutes.com/?p=1</guid>
		<description><![CDATA[ChemRoutes Corporation is pleased to announce its automated chemistry laboratories have relocated to the National Institute of Nanotechnology Innovation Centre (NIC) at the University of Alberta campus in Edmonton.
]]></description>
			<content:encoded><![CDATA[<p>ChemRoutes Corporation is pleased to announce its automated chemistry laboratories have relocated to the National Institute of Nanotechnology Innovation Centre (NIC) at the University of Alberta campus in Edmonton.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.chemroutes.com/2010/03/hello-world/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic page generated in 0.777 seconds. -->
<!-- Cached page generated by WP-Super-Cache on 2010-06-09 19:33:54 -->
<!-- Compression = gzip -->